Daewoong Co., Ltd. (KRX:003090)

Market Cap	832.13B +2.8%
Revenue (ttm)	2.07T +6.8%
Net Income	175.06B +202.4%
EPS	4,279.91 +202.3%
Shares Out	40.89M
PE Ratio	4.75
Forward PE	n/a
Dividend	200.00 (0.95%)
Ex-Dividend Date	Dec 29, 2025

Volume	49,148
Average Volume	67,815
Open	20,450
Previous Close	20,350
Day's Range	19,520 - 20,575
52-Week Range	18,870 - 30,600
Beta	0.42
RSI	33.61
Earnings Date	May 22, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 379
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2025, Daewoong's revenue was 2.07 trillion, an increase of 6.79% compared to the previous year's 1.94 trillion. Earnings were 175.06 billion, an increase of 202.43%.